Navigation Links
Novel publishing approach puts textbook in more hands
Date:10/16/2008

eness of the availability of a printed edition that may be more suitable for some readers' requirements," said Varki.

"The book's editors and Cold Spring Harbor Laboratory Press, which has published the book in print, are interested in learning how best to deliver information of the kind this textbook contains," added John Inglis, Ph.D., Cold Spring Harbor Laboratory Press's Executive Director and Publisher. "NCBI has created an online version of the book that is well-designed for scholarly reference and can be enriched with links to associated resources. We will be tracking its usage and how readers of the site respond to the availability of a print version, for both research and teaching purposes."

Geared towards graduate students, advanced undergraduates, and professional researchers, Essentials of Glycobiology is the largest, most authoritative volume available on the structure, synthesis, and biology of glycans (sugar chains), molecules that coat cell surfaces and proteins and play important roles in many normal and disease processes. The book is written and edited by leaders in the field of glycobiology who have extensive research and teaching experience. The back cover of the book features laudatory comments from eight Nobel laureates.

The online version of Essentials of Glycobiology is freely available from the NLM/NCBI Bookshelfa collection of biomedical books and other materials that have been adapted for online useat http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=glyco2. This version will be fully searchable, and there are plans to provide links to not only current, related resources in PubMed/MEDLINE, the most commonly used biomedical literature database, but also to other relevant Internet sites. The online format will also enable the editors to periodically revise and update the text, in collaboration with the Press and NCBI.


'/>"/>
Contact: Ingrid Benirschke
benirsch@cshl.edu
619-275-6021
Cold Spring Harbor Laboratory
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Cold Spring Harbor Laboratory scientists trace a novel way cells are disrupted in cancer
2. Childrens National researchers develop novel anti-tumor vaccine
3. LIAI launches new division to look at novel approaches to heart disease and inflammation
4. Conaway Lab identifies novel mechanism for regulation of gene expression
5. Scientists identify novel inhibitor of human microRNA
6. Using novel tool, UD researchers dig through cell trash and find treasure
7. Novel anti-cancer mechanism found in long-lived rodents
8. Novel fungus helps beetles to digest hard wood
9. GIANT-Coli: A novel method to quicken discovery of gene function
10. Novel structure proteins could play a role in apoptosis
11. Novel approach may protect against heart attack injury
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Novel publishing approach puts textbook in more hands
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a ... announced that its DigitalPersona ® Pro Enterprise ... have been deployed throughout First Bank branch locations ... South Carolina and Virginia. First Bank, ... Southern Pines, North Carolina , selected ...
(Date:11/21/2014)... -- Earlier this year Donald Spector , Chairman of ... the most prolific inventors in the world, got a ... to third party agencies. Spector envisioned this technology even ... earliest known patents in this area. Now major technology ... care, elder care and hospital applications. This technology has ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
... inferences about the intentions of other individuals in order ... of everyday life that we humans take for granted. ... Max Planck Institute in Germany, this ability is present ... in the April issue of Current Directions in Psychological ...
... the National Institute on Drug Abuse (NIDA), part of ... time identified genes that might increase a person’s ability ... by Dr. George Uhl at NIDA’s Intramural Research Program ... the Center for Nicotine and Smoking Cessation Research at ...
... international team of 19 researchers calls for better forecasting ... The researchers, led by Daniel B. Botkin, note that ... be at risk from global warming, surprisingly few species ... period encompassing several ice ages. They suggest that this ...
Cached Biology News:Man's best friend lends insight into human evolution 2NIDA study identifies genes that might help some people abstain from smoking 2
(Date:12/17/2014)... , Dec. 17, 2014   Synageva BioPharma ... company developing therapeutic products for rare disorders, announced today ... being held in San Francisco, CA. ... and Chief Executive Officer, will present on Monday, January ... The presentation will be webcast live and may be ...
(Date:12/15/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology,  today celebrated continued ... its exVive3D TM Human Liver Tissue.  The ... commercial release on November 18, has been recognized ... awards for innovation. Most recently, on ...
(Date:12/15/2014)... Dec. 15, 2014  Ascendis Pharma A/S, a ... to address significant unmet medical needs, today announced ... 2 pediatric study to evaluate once-weekly TransCon Growth ... GHD.  This interim analysis consists of 25 patients, ... in the study, completing all six months of ...
(Date:12/13/2014)... 12, 2014 Clarassance, a privately held ... new name: Therabron Therapeutics , Inc. The new ... (a type of structure in the lungs similar to ... to develop novel protein therapeutics for the treatment of ... to change the name to mark the company's escalation ...
Breaking Biology Technology:Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... The 2nd Aesthetic Plastic Surgery and Anti Aging Medicine: The ... in New York on June 10-12, 2011. This three day ... medicine, the science of stem cells, and fat grafting applications ... plastic surgeons Drs. Sydney Coleman and J. Peter Rubin, among ...
... American Regent is conducting a nationwide voluntary recall ... mL Single Dose VialsNDC # 0517-4901-25;andDexamethasone Sodium Phosphate Injection, ... Sodium Phosphate Injection, 4 mg/mL, 30 mL Multiple Dose ... voluntary recall, initiated on March 16, 2011 to the ...
... NEW YORK, March 16, 2011 Reportlinker.com announces ... in its catalogue: Global Specialty ... This report analyzes the worldwide markets ... following product segments - Specialty Medical Enzymes, Polymerases, ...
Cached Biology Technology:Aesthetic Plastic Surgery and Anti Aging Medicine Symposium Features New Developments in the Science of Stem Cells and Fat Grafting 2American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 2American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 3American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 4American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 5Global Specialty Enzymes Industry 2Global Specialty Enzymes Industry 3Global Specialty Enzymes Industry 4Global Specialty Enzymes Industry 5Global Specialty Enzymes Industry 6Global Specialty Enzymes Industry 7Global Specialty Enzymes Industry 8Global Specialty Enzymes Industry 9Global Specialty Enzymes Industry 10Global Specialty Enzymes Industry 11Global Specialty Enzymes Industry 12Global Specialty Enzymes Industry 13Global Specialty Enzymes Industry 14Global Specialty Enzymes Industry 15Global Specialty Enzymes Industry 16Global Specialty Enzymes Industry 17Global Specialty Enzymes Industry 18Global Specialty Enzymes Industry 19Global Specialty Enzymes Industry 20Global Specialty Enzymes Industry 21Global Specialty Enzymes Industry 22Global Specialty Enzymes Industry 23Global Specialty Enzymes Industry 24